Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

560G>A (rs4986782) (R187Q) Single Nucleotide Polymorphism in Arylamine N-Acetyltransferase 1 Increases Affinity for the Aromatic Amine Carcinogens 4-Aminobiphenyl and N-Hydroxy-4-Aminobiphenyl: Implications for Cancer Risk Assessment

Frontiers in Pharmacology(2022)10.3389/fphar.2022.820082Source: DataRank Database

560G>A (rs4986782) (R187Q) Single Nucleotide Polymorphism in Arylamine N-Acetyltransferase 1 Increases Affinity for the Aromatic Amine Carcinogens 4-Aminobiphenyl and N-Hydroxy-4-Aminobiphenyl: Implications for Cancer Risk Assessment is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.25)OA: goldTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

David W. Hein ORCID,Mark A. Doll

Live enrichment

PubMed:35273499 PMC:PMC8902414 OpenAlex:https://openalex.org/W4213085369

National Institutes of Health

Grant: R01-CA34627 P42-ES023716 P30-ES030283.

NIEHS NIH HHS

Grant: P30 ES030283

NIEHS NIH HHS

Grant: P42 ES023716

NCI NIH HHS

Grant: R01 CA034627

National Institutes of Health

Grant: 3P42ES023716-03S1

Environmental Exposure and Cardiometabolic Disease

National Institutes of Health

Grant: 3R01CA034627-10S1

PHARMACOGENETICS OF DRUG AND CARCINOGEN METABOLISM

National Institutes of Health

Grant: 3P30ES030283-05S1

University of Louisville Center for Integrative Environmental Health Sciences

FWCI

0.25

Citation Percentile

0.4%

Citation Trend

2023

2024

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fphar.2022.820082/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2022.820082/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2022.820082/full

journalhttps://doi.org/10.3389/fphar.2022.820082

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35273499

Fields of Study

Carcinogens and Genotoxicity AssessmentEpigenetics and DNA MethylationPolyamine Metabolism and Applications0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Arylamine N-acetyltransferaseN-acetyltransferaseAcetyltransferaseCarcinogenSingle-nucleotide polymorphismMolecular biologyHeterocyclic amineChemistryAcetylationNucleotideBiologyBiochemistryGeneGenotype4-aminobiphenylO-acetylationN-acetylationSingle Nucelotide PolymorphismsArylamine N-acetyltransferase 1N-Hydroxy-4-AminobiphenylPharmacologyRM1-950Pharmacology (medical)Therapeutics. Pharmacology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

560G>A (rs4986782) (R187Q) Single Nucleotide Polymorphism in Arylamine N-Acetyltransferase 1 Increases Affinity for the Aromatic Amine Carcinogens 4-Aminobiphenyl and N-Hydroxy-4-Aminobiphenyl: Implications for Cancer Risk Assessment

FAIR Checklist

Authors (2)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)